@article{bb790320d292408fbb6c2752dc49d693,
title = "Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives",
keywords = "Non-small cell lung cancer, oncogenic drivers, targeted therapy, anaplastic lymphoma kinase, anaplastic lymphoma kinase inhibitor, B Raf kinase, B Raf kinase inhibitor, epidermal growth factor receptor 2, epidermal growth factor receptor kinase inhibitor, neurotrophic tyrosine kinase receptor, oncoprotein, protein Ret, protein tyrosine kinase, protein tyrosine kinase inhibitor, ROS proto oncogene 1, scatter factor receptor, unclassified drug, advanced cancer, carcinogenesis, drug targeting, human, molecularly targeted therapy, non small cell lung cancer, oncogene, Review",
author = "C. Genova and G. Rossi and M. Tagliamento and E. Rijavec and F. Biello and L. Cerbone and L. Zullo and F. Grossi",
note = "Export Date: 16 September 2020 Correspondence Address: Genova, C.; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, Italy; email: carlo.genova@hsanmartino.it",
year = "2020",
doi = "10.1080/17476348.2020.1714441",
language = "English",
volume = "14",
pages = "367--383",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
number = "4",
}